Announced Sat, 29 Aug · 16:22 IST
Parmax Pharma allots shares and warrants on preferential basis
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Parmax Pharma allotted 31,37,586 equity shares at Rs 36.50 each (totalling about Rs 11.45 crore) and 21,45,145 convertible warrants at the same price to 14 non-promoter allottees. The warrants can be exercised within 18 months. Issue price includes a Rs 26.50 premium over the Rs 10 face value. Post-allotment, several allottees will be reclassified as promoters or promoter group members.
Likely market impact
Immediate equity dilution plus potential further dilution if warrants are converted within 18 months. Promoter reclassification suggests long-term commitment.